arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2502.18519eess.IVcs.AIcs.CV

FreeTumor:在计算机断层扫描图像中大规模生成肿瘤合成以提升肿瘤识别能力

FreeTumor: Large-Scale Generative Tumor Synthesis in Computed Tomography Images for Improving Tumor Recognition

The Hong Kong University of Science and Technology(香港科技大学);Tencent AI Lab(腾讯AI实验室);Harvard University(哈佛大学);The Chinese University of Hong Kong(香港中文大学);The Third Affiliated Hospital of Southern Medical University(南方医科大学第三附属医院);Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University(中山大学孙逸仙纪念医院);The University of Hong Kong(香港大学);Shenzhen-Hong Kong Collaborative Innovation Research Institute(深港产学研协同创新研究院)
Linshan Wu, Jiaxin Zhuang, Yanning Zhou, Sunan He, Jiabo Ma, Luyang Luo, Xi Wang, Xuefeng Ni, Xiaoling Zhong, Mingxiang Wu, Yinghua Zhao, Xiaohui Duan, Varut Va… 展开作者

Linshan Wu, Jiaxin Zhuang, Yanning Zhou, Sunan He, Jiabo Ma, Luyang Luo, Xi Wang, Xuefeng Ni, Xiaoling Zhong, Mingxiang Wu, Yinghua Zhao, Xiaohui Duan, Varut Vardhanabhuti, Pranav Rajpurkar, Hao Chen

AI总结:

FreeTumor提出生成式AI框架,利用大规模未标注CT数据合成逼真肿瘤,将训练集扩大40倍以上,经放射科医生验证及多项实验证明其显著优于现有方法。

摘要:

肿瘤是全球致死的主要原因之一,每年估计有1000万死亡病例与肿瘤相关疾病有关。基于人工智能的肿瘤识别为更精确、更智能的肿瘤筛查和诊断开辟了新的可能性。然而,标注数据集的稀缺严重阻碍了进展,这需要放射科医生付出大量的标注工作。为应对这一挑战,我们提出了FreeTumor,一个创新的生成式人工智能(GAI)框架,用于实现大规模肿瘤合成以缓解数据稀缺问题。具体而言,FreeTumor有效结合了有限的标注数据和大量未标注数据进行肿瘤合成训练。通过释放大规模数据的力量,FreeTumor能够在图像上合成大量逼真的肿瘤,以扩充训练数据集。为此,我们通过整理来自33个数据源的161,310个公开可用的计算机断层扫描(CT)体数据,创建了用于肿瘤合成和识别的最大训练数据集,其中仅2.3%包含标注肿瘤。为验证合成肿瘤的真实性,我们邀请了13位委员会认证的放射科医生参与视觉图灵测试,以区分合成肿瘤和真实肿瘤。严格的临床医生评估验证了我们合成肿瘤的高质量,因为他们在区分合成肿瘤与真实肿瘤时仅达到51.1%的敏感性和60.8%的准确率。通过高质量的肿瘤合成,FreeTumor将识别训练数据集扩大了40倍以上,展现出相对于包括各种合成方法和基础模型在内的最先进人工智能方法的显著优越性。这些发现表明FreeTumor在临床应用中的广阔前景,有望推进肿瘤治疗并提高患者的生存率。

英文摘要:

Tumor is a leading cause of death worldwide, with an estimated 10 million deaths attributed to tumor-related diseases every year. AI-driven tumor recognition unlocks new possibilities for more precise and intelligent tumor screening and diagnosis. However, the progress is heavily hampered by the scarcity of annotated datasets, which demands extensive annotation efforts by radiologists. To tackle this challenge, we introduce FreeTumor, an innovative Generative AI (GAI) framework to enable large-scale tumor synthesis for mitigating data scarcity. Specifically, FreeTumor effectively leverages a combination of limited labeled data and large-scale unlabeled data for tumor synthesis training. Unleashing the power of large-scale data, FreeTumor is capable of synthesizing a large number of realistic tumors on images for augmenting training datasets. To this end, we create the largest training dataset for tumor synthesis and recognition by curating 161,310 publicly available Computed Tomography (CT) volumes from 33 sources, with only 2.3% containing annotated tumors. To validate the fidelity of synthetic tumors, we engaged 13 board-certified radiologists in a Visual Turing Test to discern between synthetic and real tumors. Rigorous clinician evaluation validates the high quality of our synthetic tumors, as they achieved only 51.1% sensitivity and 60.8% accuracy in distinguishing our synthetic tumors from real ones. Through high-quality tumor synthesis, FreeTumor scales up the recognition training datasets by over 40 times, showcasing a notable superiority over state-of-the-art AI methods including various synthesis methods and foundation models. These findings indicate promising prospects of FreeTumor in clinical applications, potentially advancing tumor treatments and improving the survival rates of patients.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑